Parsons James T. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Parsons James T.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+13,222→ 13,222 totalExercise: $2.45Exp: 2032-05-31→ Common Shares (13,222 underlying)
Holdings
- 38,509
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 32,409 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
- [F2]Vests in four nearly equal quarterly installments over one year.